Search Results 111-120 of 11791 for Pyrogen
Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...
These mainly include conditions involving the pancreas, liver, gallbladder, esophagus, stomach, small intestine and colon. With 13 specialty groups and more ...
Research in the Division of Experimental Pathology and Laboratory Medicine at Mayo Clinic seeks to reveal the mechanisms underlying disease development and ...
A breadth of learning experiences has been designed to increase and refine clinical competency, provide evidence-based pharmacotherapeutic care plans, and ...
The purpose of this study is to evaluate whether profiling aggressive tumors for molecular alterations, together with drug testing in patient-derived 3D models, ...
The purpose of this study is to determine the effect of endoscopic cryoablation for lessening the effects of dysphagia on the quality of life (QOL) of patients ...
The first objective of this pilot research protocol is to evaluate the quality of PET from the SIGNA PET/MR system and to compare the quantitative accuracy of ...
About this study. The purpose of this study is to establish at least 200 patient-derived cancer xenografts (PDXs), and to utilize these PDXs in preclinical ...
About this study. The purpose of this study is to use genomic and proteomic analyses to identify possible diagnostic markers and potential drugs for ...
Sept. 20, 2024. A bimonthly publication for physicians that discusses trends and advances in neurology and neurosurgery at Mayo Clinic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.